Extracellular Vesicles for HD
Part of paid clinical trials in Orlando, Florida.
- Sponsor
- University of Central Florida
- Study ID
- NCT06082713
- Status
- Recruiting
Conditions
Eligibility Criteria
- Sex
- ALL
- Age
- 18 Years - 75 Years
- Healthy Volunteers
- Accepted
Study Details
The primary objective of this study is to discover blood-based biomarker of brain Huntingtin (HTT) protein using extracellular vesicles to be used in evaluating target engagement in HTT lowering clinical trials. Secondary objectives of this study include developing more accurate biomarkers of Huntington disease (HD) progression or conversion and to develop standard practices for extracellular vesicle biomarker discovery research. The investigators hypothesize that brain-derived extracellular vesicles (EVs) isolated from human biofluids contain biological cargo specific to their tissue of origin that could allow their use as brain biomarkers for HD. EVs are lipid bilayer-delimited particles that are naturally released from cells in the brain. The investigators will investigate if EVs contents reflect the pathological alterations occurring with disease progression when compared with EVs isolated from biofluids of healthy non-HD persons.
Key Dates
- Start date
- Oct 25, 2023
- Status verified
- Dec 2024
- Primary completion
- Nov 30, 2031
- Completion
- Nov 30, 2031
Study Design
- Enrollment
- 100 participants (estimated)
Arms
- Arm: Huntington Disease Carriers
- Arm: Non-Huntington Disease Carriers
Primary Outcome Measure
To discover blood-based biomarker of brain HTT protein using extracellular vesicles to be used in evaluating target engagement in HTT lowering clinical trials. [ Time Frame: 1 year ]
Central Contacts
- Amoy Fraser, PhD, CCRP, PMP4072668742
- Erica Martin, B.S.4072668742
Locations (1)
| Facility | City | State | ZIP | Site coordinators |
|---|---|---|---|---|
| University of Central Florida | Orlando | Florida | 32816 | Amber Southwell, PhD |
Find similar trials in Orlando, FL
Related Studies
- Gut Microbiomes in HDRecruiting · University of Central Florida · Orlando, Florida
- Frequency of Selected Single Nucleotide Polymorphisms in Huntington Disease Gene Expansion CarriersRecruiting · Hoffmann-La Roche · Birmingham, Alabama
- Gait Analysis in Neurological DiseaseRecruiting · Beth Israel Deaconess Medical Center · Boston, Massachusetts
- Retinal Imaging in Neurodegenerative DiseaseRecruiting · Duke University · Durham, North Carolina